Chronic heart failure and hypoalbuminaemia are linked to a poor antibody response at 3 months after the third dose of the ...

RNA-1010 demonstrated superior relative vaccine efficacy that was 26.6% (95% CI; 16.7%, 35.4%) higher than a licensed ...

The virus has not yet evolved to spread efficiently between people. Excellent vaccine technology exists, but the government ...

Monkeypox Vaccine and Treatment revenue is expected to grow at a CAGR of 10.20% from 2025 to 2032, reaching nearly USD 225.12 Mn by 2032.

Learn about June 2025’s top biotech deals, featuring major collaborations in small molecules, protein therapeutics, and ...

HHS Sec. RFK Jr. says Dr. Anthony Fauci is likely liable for the origins of the COVID-19 pandemic, calling for a nationwide ...

Meta Platforms Inc.’s (META) shares rose 0.6% after the company recruited several key AI researchers for its newly developed superintelligence labs. Shares of Moderna Inc. (MRNA) gained 1.6% after its ...

ACIP voted to recommend against anyone — adult, child and pregnant person — receiving a seasonal flu vaccine with the mercury ...

Trump and Musk reignite feud over tax bill, stocks end first half at records, Moderna flu vaccine achieves promising results, ...

Sabic to close UK cracker, plastics recycler Novoloop raises funds, Kymera strikes molecular glue deal, and more ...

Explore the latest health technology that is changing the pharma industry, and discover how these innovations could solve key ...

As the company invests heavily in expanding its non-COVID mRNA vaccine pipeline, the OpenAI partnership positions it to leverage AI’s full potential in accelerating drug development.